BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33215544)

  • 1. Novel free-circulating and extracellular vesicle-derived miRNAs dysregulated in Duchenne muscular dystrophy.
    Catapano F; Scaglioni D; Maresh K; Ala P; Domingos J; Selby V; Ricotti V; Phillips L; Servais L; Seferian A; Groot I; Krom YD; Voit T; Verschuuren JJGM; Niks EH; Straub V; Morgan J; Muntoni F
    Epigenomics; 2020 Nov; 12(21):1899-1915. PubMed ID: 33215544
    [No Abstract]   [Full Text] [Related]  

  • 2. Downregulation of miRNA-29, -23 and -21 in urine of Duchenne muscular dystrophy patients.
    Catapano F; Domingos J; Perry M; Ricotti V; Phillips L; Servais L; Seferian A; Groot I; Krom YD; Niks EH; Verschuuren JJ; Straub V; Voit T; Morgan J; Muntoni F
    Epigenomics; 2018 Jul; 10(7):875-889. PubMed ID: 29564913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of circulating miRNAs in Duchenne disease: Association with muscle injury and metabolic parameters.
    Almeida-Becerril T; Rodríguez-Cruz M; Hernández-Cruz SY; Ruiz-Cruz ED; Mendoza CRS; Cárdenas-Conejo A; Escobar-Cedillo RE; Ávila-Moreno F; Aquino-Jarquin G
    Acta Neurol Scand; 2022 Nov; 146(5):512-524. PubMed ID: 36000352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating MicroRNAs in Duchenne Muscular Dystrophy.
    Mousa NO; Abdellatif A; Fahmy N; Zada S; El-Fawal H; Osman A
    Clin Neurol Neurosurg; 2020 Feb; 189():105634. PubMed ID: 31838454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in Abundance and Compartmentalization of miRNAs in Blood Plasma Extracellular Vesicles and Extracellular Condensates during HIV/SIV Infection and Its Modulation by Antiretroviral Therapy (ART) and Delta-9-Tetrahydrocannabinol (Δ
    Kopcho S; McDew-White M; Naushad W; Mohan M; Okeoma CM
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum profiling identifies novel muscle miRNA and cardiomyopathy-related miRNA biomarkers in Golden Retriever muscular dystrophy dogs and Duchenne muscular dystrophy patients.
    Jeanson-Leh L; Lameth J; Krimi S; Buisset J; Amor F; Le Guiner C; Barthélémy I; Servais L; Blot S; Voit T; Israeli D
    Am J Pathol; 2014 Nov; 184(11):2885-98. PubMed ID: 25194663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs as serum biomarkers in Becker muscular dystrophy.
    Gagliardi D; Rizzuti M; Brusa R; Ripolone M; Zanotti S; Minuti E; Parente V; Dioni L; Cazzaniga S; Bettica P; Bresolin N; Comi GP; Corti S; Magri F; Velardo D
    J Cell Mol Med; 2022 Sep; 26(17):4678-4685. PubMed ID: 35880500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.
    Endzeliņš E; Berger A; Melne V; Bajo-Santos C; Soboļevska K; Ābols A; Rodriguez M; Šantare D; Rudņickiha A; Lietuvietis V; Llorente A; Linē A
    BMC Cancer; 2017 Nov; 17(1):730. PubMed ID: 29121858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNome profiling in Duchenne muscular dystrophy; identification of asymptomatic and manifesting female carriers.
    Mousa NO; Sayed AA; Fahmy N; Elzayat MG; Bakry U; Abdellatif A; Zahra WK; Osman A
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34472584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Cardiomyopathy-Associated Circulating miRNA Biomarkers in Muscular Dystrophy Female Carriers Using a Complementary Cardiac Imaging and Plasma Profiling Approach.
    Florian A; Patrascu A; Tremmel R; Rösch S; Sechtem U; Schwab M; Schaeffeler E; Yilmaz A
    Front Physiol; 2018; 9():1770. PubMed ID: 30622476
    [No Abstract]   [Full Text] [Related]  

  • 11. Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy.
    Zaharieva IT; Calissano M; Scoto M; Preston M; Cirak S; Feng L; Collins J; Kole R; Guglieri M; Straub V; Bushby K; Ferlini A; Morgan JE; Muntoni F
    PLoS One; 2013; 8(11):e80263. PubMed ID: 24282529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker Potential of Extracellular miRNAs in Duchenne Muscular Dystrophy.
    Coenen-Stass AML; Wood MJA; Roberts TC
    Trends Mol Med; 2017 Nov; 23(11):989-1001. PubMed ID: 28988850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs as a Tool for Differential Diagnosis of Neuromuscular Disorders.
    Mousa NO; Abdellatif A; Fahmy N; El-Fawal H; Osman A
    Neuromolecular Med; 2023 Dec; 25(4):603-615. PubMed ID: 37856057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The FibromiR miR-214-3p Is Upregulated in Duchenne Muscular Dystrophy and Promotes Differentiation of Human Fibro-Adipogenic Muscle Progenitors.
    Arrighi N; Moratal C; Savary G; Fassy J; Nottet N; Pons N; Clément N; Fellah S; Larrue R; Magnone V; Lebrigand K; Pottier N; Dechesne C; Vassaux G; Dani C; Peraldi P; Mari B
    Cells; 2021 Jul; 10(7):. PubMed ID: 34360002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digital PCR quantification of miR-30c and miR-181a as serum biomarkers for Duchenne muscular dystrophy.
    Llano-Diez M; Ortez CI; Gay JA; Álvarez-Cabado L; Jou C; Medina J; Nascimento A; Jimenez-Mallebrera C
    Neuromuscul Disord; 2017 Jan; 27(1):15-23. PubMed ID: 27979502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum miR-206 and other muscle-specific microRNAs as non-invasive biomarkers for Duchenne muscular dystrophy.
    Hu J; Kong M; Ye Y; Hong S; Cheng L; Jiang L
    J Neurochem; 2014 Jun; 129(5):877-83. PubMed ID: 24460924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of circulating miRNAs differentially expressed in patients with Limb-girdle, Duchenne or facioscapulohumeral muscular dystrophies.
    García-Giménez JL; García-Trevijano ER; Avilés-Alía AI; Ibañez-Cabellos JS; Bovea-Marco M; Bas T; Pallardó FV; Viña JR; Zaragozá R
    Orphanet J Rare Dis; 2022 Dec; 17(1):450. PubMed ID: 36575500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-708-5p and miR-34c-5p are involved in nNOS regulation in dystrophic context.
    Guilbaud M; Gentil C; Peccate C; Gargaun E; Holtzmann I; Gruszczynski C; Falcone S; Mamchaoui K; Ben Yaou R; Leturcq F; Jeanson-Leh L; Piétri-Rouxel F
    Skelet Muscle; 2018 Apr; 8(1):15. PubMed ID: 29703249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of circulating extracellular vesicle derived microRNAs in breast cancer patients with obesity: a potential role for Let-7a.
    Barone I; Gelsomino L; Accattatis FM; Giordano F; Gyorffy B; Panza S; Giuliano M; Veneziani BM; Arpino G; De Angelis C; De Placido P; Bonofiglio D; Andò S; Giordano C; Catalano S
    J Transl Med; 2023 Mar; 21(1):232. PubMed ID: 37004031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of circulating extracellular vesicle-associated microRNAs in cortisol-producing adrenocortical tumors.
    Perge P; Decmann Á; Pezzani R; Bancos I; Fassina A; Luconi M; Canu L; Tóth M; Boscaro M; Patócs A; Igaz P
    Endocrine; 2018 Feb; 59(2):280-287. PubMed ID: 29299796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.